TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,283,047 | -43.6% | 392,709 | +67.6% | 0.53% | -36.6% |
| Q2 2023 | $5,820,459 | +65.8% | 234,318 | +0.4% | 0.84% | +56.7% |
| Q1 2023 | $3,511,419 | -67.7% | 233,472 | -16.8% | 0.53% | -51.1% |
| Q2 2021 | $10,880,000 | -10.9% | 280,486 | +10.7% | 1.09% | -5.7% |
| Q1 2021 | $12,208,000 | +62.5% | 253,271 | +75.4% | 1.16% | +45.5% |
| Q4 2020 | $7,512,000 | +4.4% | 144,414 | -46.3% | 0.80% | -24.4% |
| Q3 2020 | $7,193,000 | – | 268,804 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,890,000 | $15,800,400 | 5.14% |
| Ghost Tree Capital, LLC | 1,000,000 | $8,360,000 | 2.75% |
| Soleus Capital Management, L.P. | 2,884,382 | $24,113,434 | 2.22% |
| M28 Capital Management LP | 216,600 | $1,810,776 | 2.08% |
| Paradigm Biocapital Advisors LP | 3,619,015 | $30,254,965 | 2.05% |
| 683 Capital Management, LLC | 1,350,000 | $11,286,000 | 0.88% |
| Parkwood LLC | 165,414 | $6,081 | 0.66% |
| Spotlight Asset Group, Inc. | 79,000 | $660,440 | 0.60% |
| Pier Capital, LLC | 392,709 | $3,283,047 | 0.53% |
| Quantum Private Wealth, LLC | 91,081 | $761,438 | 0.36% |